Mrv1909 02192003292 d 21 24 0 0 0 0 999 V2000型0.4879 -0.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2806 -0.4573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4879 0.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2221 1.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2221 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2806 0.8711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9408 0.6228 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.7641 0.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9408 -0.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2719 -2.1866 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.2221 1.8642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0106 -2.9924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9365 2.2737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1873 -2.9924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7641 2.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3546 2.9924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6142 -1.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6595 -0.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0522 -2.2084 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.4592 -2.0951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.6882 -1.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 2 0 0 0 0 4 1 3 0 0 0 0 5 1 1 0 0 0 0 6 3 1 0 0 0 0 7 9 1 0 0 0 0 8 2 1 0 0 0 0 9 5 10 2 0 0 0 0 2 1 1 0 0 0 11 4 1 0 0 0 0 12 10 1 0 0 0 0 13 11 1 0 0 0 0 14 12 2 0 0 0 0 15 13 1 0 0 0 0 16 13 1 0 0 0 0 17 10 1 0 0 0 0 18 9 1 0 0 0 0 19日17日1 0 0 0 0 20 21 1 0 0 0 0 19日21日1 1 0 0 0 8 6 2 0 0 0 0 7 4 2 0 0 0 0 19 14 1 0 0 0 0 16 15 1 0 0 0 0 M >结束
DB01048 >
drugbank >
NC1 = NC2 = C (N = CN2 [C@@H] 2 C [C@H] (CO) C = C2) C (NC2CC2) = N1 >
InChI = 1 s / C14H18N6O c15-14-18-12(17-9-2-3-9) 11 - 13(第4)20 (7-16-11)10-4-1-8 (5 - 10)6-21 / h1, 4、7、21 h, 2 - 3, 5-6H2, (H3、15、17、18、19) / t8 -, 10 + / m1 / s1 >
MCGSCOLBFJQGHM-SCZZXKLOSA-N >
C14H18N6O >
286.3323 >
286.154209228 >
6 >
39 >
1.3727912179652686 >
30.43244347040572 >
1 >
3 >
0 >
1 >
[(1 s, 4 r) 4 - [2-amino-6 - (cyclopropylamino) 9 h-purin-9-yl] cyclopent-2-en-1-yl]甲醇>
0.61 >
0.38677390133333256 >
-2.37 >
0 >
1 >
4 >
0 >
16.707791784419957 >
15.406517692248412 >
5.798825079411383 >
101.88000000000001 >
82.62310000000001 >
4 >
1 >
1.21 e + 00 g / l >
abacavir >
0 >
DB01048 >
APRD00216 >
批准;临床实验的>
Abacavir >
{(1 s-cis) 4 - [2-amino-6 - (cyclopropylamino) 9 h-purin-9-yl] cyclopent-2-en-1-yl}甲醇;Abacavir;美国广播公司(ABC) >
Abacavir;Abacavir硫酸;Abacavir硫酸,拉米夫定与齐多夫定;Abacavir和拉米夫定;Abacavir和拉米夫定;Abacavir,拉米夫定与齐多夫定;Apo-abacavir;Apo-abacavir-lamivudine;Apo-abacavir-lamivudine平板电脑;Apo-abacavir-lamivudine-zidovudine; Auro-abacavir/lamivudine; Epzicom; Jamp Abacavir / Lamivudine; Kivexa; Mint-abacavir; Mint-abacavir/lamivudine; Mylan-abacavir/lamivudine; PMS-abacavir-lamivudine; Teva-abacavir/lamivudine; Triumeq; Triumeq PD; Trizivir; Ziagen >
Abacavir盐酸盐;Abacavir盐酸盐一水化物;硫酸Abacavir $ $ $ $